专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

EP3835304B1 OPTICALLY ACTIVE BRIDGED PIPERIDINE DERIVATIVE 有权
公开(公告)号：EP3835304B1
公开(公告)日：2024-10-09
申请号：EP19846598.1
申请日：2019-08-07
IPC分类号： C07D519/00 , A61K31/439 , A61K45/00 , A61P35/00 , A61P35/02 , A61P43/00 , C07D495/04
CPC分类号： A61P35/00 , A61P35/02 , A61P43/00 , C07D519/00 , A61K45/06

2. 发明公开

EP4428227A1 PRODUCTION METHOD FOR SHEET-LIKE RETINAL TISSUE 审中-实审
公开(公告)号：EP4428227A1
公开(公告)日：2024-09-11
申请号：EP22895708.0
申请日：2022-11-18
申请人： RIKEN , Sumitomo Pharma Co., Ltd.
发明人： MANDAI, Michiko , TAKAHASHI, Masayo , YAMASAKI, Suguru , HORIUCHI, Matsuri
IPC分类号： C12N5/071 , A61K35/30 , A61L27/36 , A61L27/38 , A61L27/52 , A61L27/58 , A61P27/02 , C07K14/78 , C12M3/00 , C12N5/074
CPC分类号： A61K35/30 , A61L27/36 , A61L27/38 , A61L27/52 , A61L27/58 , A61P27/02 , C07K14/78 , C12M3/00 , C12N5/06
摘要： A method for manufacturing a cell aggregate comprising retinal tissue having a layer structure, comprising suspension-culturing or adhesion-culturing a dispersed retinal cell population in a culture medium containing a Wnt signaling pathway agonist, wherein the retinal cell population comprises one or more cells selected from the group consisting of a retinal progenitor cell and a photoreceptor progenitor cell.

3. 发明公开

EP4400053A1 BIOLOGICAL INFORMATION RECORDING DEVICE AND BIOLOGICAL INFORMATION RECORDING PROGRAM 审中-实审
公开(公告)号：EP4400053A1
公开(公告)日：2024-07-17
申请号：EP22867350.5
申请日：2022-09-06
申请人： Sumitomo Pharma Co., Ltd.
发明人： YOSHIMIZU, Minoru , OCHIAI, Yasushi , FUKUSHIMA, Yumiko , SADAMOTO, Yuiko , IZUNO, Toru , KOYAMA, Hiroaki
IPC分类号： A61B5/377
CPC分类号： A61B5/377
摘要： A biological information recording device as an example of the present disclosure includes: an acquisition processor configured to acquire biological information on a subject, which is detected by a biological information sensor; and a recording processor configured to record the biological information acquired by the acquisition processor, and to further record, when a designation operation that designates a task to be carried out by the subject is performed by an observer who observes the subject during recording of the biological information, the task in association with the biological information.

4. 发明公开

EP4400052A1 BRAIN WAVE MEASUREMENT DEVICE 审中-实审
公开(公告)号：EP4400052A1
公开(公告)日：2024-07-17
申请号：EP22867351.3
申请日：2022-09-06
申请人： Sumitomo Pharma Co., Ltd.
发明人： YOSHIMIZU, Minoru , OCHIAI, Yasushi , MASAYOSHI, Sadao
IPC分类号： A61B5/369 , A61B5/256 , A61B5/291
CPC分类号： A61B5/291 , A61B5/369 , A61B5/256
摘要： An object of the present invention is to provide a wearable brain wave measurement device having a structure that can achieve both of improvement of durability and improvement of fitting feeling in order to contribute to improvement of the quality of a brain wave signal to be measured. The present invention provides a brain wave measurement device wearable on a living body head, the brain wave measurement device including a housing unit including at least a central front-side component, a left front-side component, a right front-side component, and a rear-side component, the housing unit having a curved shape such that the housing unit is disposed along the living body head from a left temporal region through a frontal region to a right temporal region at a time of wearing, at least one measurement electrode that is fixed to the rear-side component and comes into contact with the frontal region at the time of wearing, and a signal processing unit housed in the housing unit, the signal processing unit processing an electric signal obtained via the measurement electrode. Rigidities of at least two components among the central front-side component, the left front-side component, the right front-side component, and the rear-side component are different from each other.

5. 发明授权

EP3770162B1 DIHYDROCHROMENE DERIVATIVES 有权转让
公开(公告)号：EP3770162B1
公开(公告)日：2023-03-15
申请号：EP19770755.7
申请日：2019-03-19
发明人： BAN, Hitoshi , KAMIOKA, Seiji , SAWAYAMA, Yusuke , HASHIZUME, Miki
IPC分类号： C07D491/20 , A61K31/436 , A61P35/00

6. 发明授权

EP3199175B1 PHARMACEUTICAL COMPOSITION FOR INJECTION 有权转让
公开(公告)号：EP3199175B1
公开(公告)日：2022-03-23
申请号：EP15844271.5
申请日：2015-09-26
发明人： TANAKA, Satoshi , NAKATANI, Tomomi
IPC分类号： A61K47/26 , A61K39/00 , C07K14/47 , A61K9/19 , A61K47/12 , A61K47/18 , A61P35/00

7. 发明公开

EP3903789A1 THERAPEUTIC DRUG FOR DISEASE ACCOMPANIED BY DISORDERS IN RETINAL SYSTEM CELLS OR RETINAL TISSUE 审中-实审转让
公开(公告)号：EP3903789A1
公开(公告)日：2021-11-03
申请号：EP19903001.6
申请日：2019-12-27
申请人： RIKEN , Sumitomo Dainippon Pharma Co., Ltd. , SUMITOMO CHEMICAL COMPANY LIMITED
发明人： SUGITA Sunao , MANDAI Michiko , TAKAHASHI Masayo , YAMASAKI Suguru
IPC分类号： A61K31/573 , A61K45/00 , A61P27/02 , A61K35/30
摘要： The present invention relates to a therapeutic drug for a disease accompanied by a disorder in retinal cells or a retinal tissue, the drug including a retinal tissue, the retinal tissue being of an allogeneic origin and having a three-dimensional structure, wherein an intended patient to be given the therapeutic drug is a patient affected by a disease accompanied by a disorder of retinal cells or a retinal tissue, to be given systemically, for 1 month or more after the administration of the therapeutic drug, no immunosuppressive agent aimed at preventing graft rejection.

8. 发明公开

EP3865146A1 PROPHYLACTIC OR THERAPEUTIC DRUG FOR BENIGN TUMOR 审中-实审转让
公开(公告)号：EP3865146A1
公开(公告)日：2021-08-18
申请号：EP19868580.2
申请日：2019-10-04
申请人： International Institute of Cancer Immunology, Inc. , Sumitomo Dainippon Pharma Co., Ltd.
发明人： SUGIYAMA Haruo
IPC分类号： A61K38/04 , A61K39/39 , A61K48/00 , A61P35/00 , C07K14/82 , C12N5/0783 , C12N5/10 , C12N15/12
摘要： The present disclosure provides a composition for preventing or treating a benign tumor. Provided is a composition for preventing or treating a benign tumor that comprises a WT1 peptide or an analog thereof, or a nucleic acid molecule encoding a WT1 peptide or an analog thereof. In a specific embodiment, the present disclosure provides a composition for preventing or treating a benign tumor that comprises a WT1 peptide or an analog thereof, or a nucleic acid molecule encoding a WT1 peptide or an analog thereof. In a preferred embodiment, the composition for preventing or treating a benign tumor (e.g. familial adenomatous polyposis) according to the present disclosure comprises a killer type WT1 peptide and/or a helper type WT1 peptide. In a further preferred embodiment, the WT1 peptide is WT1 126 killer peptide and/or WT1 35 helper peptide. In another aspect, provided are a method of inducing WT1 peptide-specific CTLs, a method of inducing WT1-specific helper T cells, and a method of inducing dendritic cells presenting a WT1 peptide.

9. 发明公开

EP3845533A1 OPTICALLY ACTIVE AZABICYCLIC DERIVATIVE 审中-实审转让
公开(公告)号：EP3845533A1
公开(公告)日：2021-07-07
申请号：EP19854536.0
申请日：2019-08-26
申请人： Sumitomo Dainippon Pharma Co., Ltd.
发明人： KAMIOKA, Seiji , BAN, Hitoshi , SHIMADA, Naoaki , HIROSE, Wataru , ARAKAWA, Akihiko , YAMAZAKI, Kazuto , HIRA, Kenjiro
IPC分类号： C07D471/10 , A61K31/506 , A61K45/00 , A61P35/00 , A61P35/02 , A61P43/00 , C07D487/10
摘要： The present invention relates to the compound of formula (1a) wherein p is 1 or 2, R 1 - R 4 are hydrogen atom or the like, and a - d are 1 or 2, or a pharmaceutically acceptable salt thereof, which has an antitumor effect by inhibiting the binding between a MLL fusion protein that is infused with AF4, AF9, or the like, which is a representative fusion partner gene causing MLL leukemia, and menin.

10. 发明公开

EP3828182A1 FUSED RING LACTAM DERIVATIVES 审中-实审转让
公开(公告)号：EP3828182A1
公开(公告)日：2021-06-02
申请号：EP19841329.6
申请日：2019-07-22
申请人： Sumitomo Dainippon Pharma Co., Ltd.
发明人： YOSHINAGA, Hidefumi , IKUMA, Yohei , IKEDA, Junya , ADACHI, Satoshi , MITSUNUMA, Harunobu , AIHARA, Yoshinori , BESNARD, Jeremy , BELL, Andrew Simon
IPC分类号： C07D413/12 , A61K31/4545 , A61K31/496 , A61K31/519 , A61K31/55 , A61P25/18 , A61P25/22 , A61P25/24 , A61P43/00 , C07D417/12 , C07D471/04 , C07D471/10 , C07D487/04 , C07D498/04
摘要： The present invention relates to a medicament for treating neuropsychiatric diseases, comprising a compound of Formula (1):

or a pharmaceutically acceptable salt thereof, as an active ingredient.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式